Table 2.
Association between selenium and FBG, HOMA-IR, and T2D
| Model 1 | Model 2 | Model 3 | ||||
|---|---|---|---|---|---|---|
| β/OR (95%CI) | P-value | β/OR (95%CI) | P-value | β/OR (95%CI) | P-value | |
| Dietary selenium | ||||||
| FBG | -0.00 (-0.01, 0.01) | 0.4748 | -0.00 (-0.01, 0.01) | 0.6876 | -0.00 (-0.02, 0.01) | 0.4718 |
| HOMA-IR | 0.01 (-0.00, 0.02) | 0.1677 | 0.01 (-0.00, 0.02) | 0.1580 | 0.00 (-0.01, 0.02) | 0.7852 |
| T2D | 1.00 (0.99, 1.00) | 0.3216 | 1.00 (0.99, 1.01) | 0.5483 | 1.00 (0.98, 1.02) | 0.9305 |
| Serum selenium | ||||||
| FBG | 0.03 (0.01, 0.05) | 0.0009 | 0.03 (0.01, 0.05) | 0.0044 | 0.03 (0.01, 0.05) | 0.0010 |
| HOMA-IR | 0.01 (-0.02, 0.03) | 0.6481 | -0.01 (-0.02, 0.03) | 0.7193 | 0.01 (-0.02, 0.03) | 0.5057 |
| T2D | 1.03 (1.01, 1.05) | 0.0075 | 1.03 (1.01, 1.06) | 0.0119 | 1.04 (1.00, 1.08) | 0.0273 |
Model 1 adjusted for: none
Model 2 adjusted for: age, race/ethnicity
Model 3 adjusted for: age, race/ethnicity, education level, PIR, six-month period when the examination was performed, BMI, WC, LDL-C, TC, energy, total fat, parity, gestational diabetes, oral contraceptive use, females hormone use, any babies weigh 9 lbs or more
PIR Ratio of family income to poverty, BMI Body Mass Index, WC Waist Circumference, LDL-C LDL-cholesterol, TC Total Cholesterol, FBG Fasting Blood Glucose, T2D Type 2 Diabetes